ESMO WORLD CONGRESS ON GASTROINTESTINAL CANCER

ESMO 22nd World Congress on Gastrointestinal Cancer

 

1-4 July 2020 Barcelona
Close
N. Poster
Poster title
Applicant name
Status
  P-001 LINC00184 promotes the stemness and chemoresistance of gastric cancer by interacting with YAP and by promoting exosomes-mediated macrophage M2 polarization Haiyan Piao Received Received
  SO-001 Prognostic nomogram to predict overall survival in patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: Real-world results from the multicenter retrospective study (NAPOLEON study) Taro Shibuki Received Received
  P-005 Economic Burden of HCC And The Need Of Innovative Treatments Abdalla Abotaleb Received Received
  P-006 Perioperative FLOT: Tolerability, pathological response rates, and the role of adjuvant phase ERCAN ZDEN Received Received
  SO-006 The influence of liver function on the outcomes of phase II trial of sorafenib vs. hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma Satoshi Kobayashi Received Received
  SO-007 Efficacy and safety of transarterial chemoembolization (TACE) plus apatinib as compared with TACE alone for recurrent hepatocellular carcinoma: A prospective randomized controlled trial Huiying Gu Received Received
  P-008 Risk factors of severe gastric dysplasia and gastric cancer in rural areas of China among individuals at high-risk: A population-based, cross-sectional study Maomao Cao Received Received
  P-009 A randomized study of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 as first-line treatment for unresectable metastatic colorectal cancer Said Belhadef Received Received
  PD-012 Clinical, pathological and molecular profiles of G3 neuroendocrine tumors and neuroendocrine carcinomas Rodrigo Taboada Received Received
  O-014 Young adults with neuroendocrine tumors present a high rate of pathogenic or likely pathogenic germline variants in cancer-predisposing genes Rachel Riechelmann Received Received
  P-15 Combined Gastrectomies: Survival Outcomes in Patients with Local Advanced Gastric Cancer Oleg Kshivets Received Received
  O-018 Tumor mutational load, microsatellite instability, BRCAness, and actionable alterations in metastatic colorectal cancer: Results from the TRIBE2 study Carlotta Antoniotti Received Received
  P-020 Identification of predictive biomarkers in colorectal adenocarcinoma Lyudmila Akhmaltdinova Received Received
  P-028 Impact of p-mTOR expression on molecular-guided therapy strategies in therapy-refractory metastatic pancreatic ductal adenocarcinoma Hossein Taghizadeh Received Received
  P-033 Regorafenib and trifluridine/tipiracil efficacy and safety in chemorefractory metastatic colorectal cancer patients: A single Bulgarian centre retrospective study Nikolay Conev Received Received
  SO-033 Clonal ion of RAS mutant metastatic colorectal cancer into RAS wild-type during first-line therapy Alexander Baraniskin Received Received
  SO-037 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504) SATOSHI YUKI Received Received
  P-039 Prognostic impact of the number of administrations of oxaliplatin in the adjuvant treatment of stage III colon cancer Joana Reis Received Received
  P-042 Primary malignant melanoma of anorectal region: An institutional experience in AIIMS Patna JAGJIT PANDEY Received Received
  P-045 Applicable value of transanal endoscopic microsurgery for high-risk rectal adenoma and early rectal cancer: Experience from 126 cases Yunhao Li Received Received
  P-048 First evidence for the antitumor activity of nanoliposomal irinotecan in metastatic biliary tract cancer Hossein Taghizadeh Received Received
  P-051 Immunoscore in rectal cancer patients receiving radiation followed by mFOLFOX with avelumab Ali Shamseddine Received Received
  P-052 The diagnostic dilemma between chronic pancreatitis and pancreatic cancer Turon Mirzaev Received Received
  P-053 Clinical evaluation of complex treatment of colorectal cancer with liver metastases Marufjon Salokhiddinov Received Received
  P-054 BISQUIT: A randomized phase II study of the administration of prebiotics and probiotics during definitive treatment with chemotherapy-radiotherapy for patients with squamous cell carcinoma of the anal canal Rachel Riechelmann Received Received
  P-055 GASTHER2: Efficacy of adding trastuzumab to standard chemotherapy in patients with advanced HER2-negative gastric cancer and HER2-positive expression in circulating tumor cells Rachel Riechelmann Received Received
  P-056 Importance determination of interleukin-6 in bile and blood in tumours of the bileopancreatoduodenal zone Marufjon Salokhiddinov Received Received
  P-058 Survival and prognostic factors in metastatic gastric cancer: results from a Bangladeshi cohort Md Shuayb Received Received
  P-067 Short-term outcomes of capecitabine plus oxaliplatin versus S-1 plus oxaliplatin as adjuvant chemotherapies for advance gastric cancer after laparoscopic gastrectomy and D2 resection: A prospective, multicenter randomized, controlled clinical trial Yongjia Yan Received Received
  P-071 Prognostic biomarkers of therapy by hepatic radioembolization with Ytrio-90 spheres in colorectal liver metastases Eva M Triviño-Ibáñez Received Received
  P-072 Biomarkers of survival and therapeutic response to hepatic radioembolization with Ytrio-90 spheres in hepatocellular carcinoma Eva M Triviño-Ibáñez Received Received
  P-127 Potential mechanism of circRNA 000585 in cholangiocarcinoma Fengming Yi Received Received
  P-128 A novel combination of GEMOX and apatinib in treatment of unresectable or metastatic cholangiocellular carcinoma Fengming Yi Received Received
  P-134 Total neoadjuvant therapy in locally advanced rectal cancer patients: A tertiary medical center experience Ali Shamseddine Received Received
  P-147 Efficacy and safety data of trifluridine/tipiracil treatment in advanced colorectal cancer based on the experience of Juan Ramón Jiménez Hospital in Huelva María Amor Urbano Received Received
  P-173 The role of maintenance therapy in the first and second lines of treatment of metastatic colorectal cancer Danila Gridnev Received Received
  P-189 Role of radiomics in clinical prognostication and prediction of survival among a cohort of metastatic intrahepatic cholangiocarcinoma Venkata pradeep babu koyyala Received Received
  P-192 ART SCORE in determining the feasibility of TACE in hepatocarcinoma Filipa Macedo Received Received
  P-200 Bone metastases from colorectal cancer correlate with biological characteristics of primary tumors: A retrospective analysis from a single institution Emilio Francesco Giunta Received Received
  P-211 Prognostic value of interleukin-6 in colon cancer patients: a prospective study in 60 Tunisian patients Ichrak Ben Abdallah Received Received
  P-221 Clinical and pathological characteristics of patients with gastrointestinal neuroendocrine tumors in the United States Dina El-Habashy Received Received
  P-232 Clinical Outcomes and Characteristics According to Localization of Colorectal Cancer In Fundacion Santa Fe De Bogota Between May 2015- May 2019 Luis Pino Received Received
  P-291 Retrospective comparison efficacy and toxicity FOLFIRI plus aflibercept or bevacizumab in patients with metastatic colorectal cancer: Results of the multicenter observational study Mikhail Fedyanin Received Received
  P-305 Efficacy and safety of IMATINIB in gastrointestinal stromal tumors: Experience of the medical oncology department of the CHU Hassan II of FES Nouiakh Lamyae Received Received
  P-307 Colorectal cancer in young people under 45: Experience of the medical oncology service of the Hospital Hassan II of FEZ Nouiakh Lamyae Received Received
  P-309 Correlation between baseline CEA levels and TNM stage at presentation in colorectal cancers in an Indian population Venkata pradeep babu koyyala Received Received
  P-313 Management of frail patients with metastatic pancreatic ductal adenocarcinoma: A single-institution experience Andrea Plaja Salarich Received Received
  P-328 Biliary tract cancers: Epidemiology and trends in Tunisian patients Ichrak Ben Abdallah Received Received
  P-345 Evaluation of a fully automated Idylla test system for microsatellite instability in a cohort of Spanish patients with colorectal carcinoma in a single institution Miriam Perez García Received Received
  P-350 Maintenance Trastuzumab in the setting of second line treatment in HER2 overexpressing metastatic gastric and gastroesophageal junction adenocarcinoma: a single center experience López López Flora Received Received
  P-355 Trastuzumab-based treatment of HER2-positive metastatic gastric cancer &304;zzet Do&287;an Received Received
  P-357 The Frequencies and Prognostic Significance of ABO Blood and Rhesus (D) Groups in HER2-Positive Gastric Cancer &304;zzet Do&287;an Received Received
  P-362 SIBO and lactose intolerance in patients receiving chemotherapy treatment for colorectal or gastric cancer Nora Forones Received Received
  P-367 A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries Omkara Veeranki Received Received
  P-369 Quality of life of caregivers of patients with gastrointestinal cancer Nora Forones Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:30 Fri 8:30-15:00
13:17
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

ESMO WORLD CONGRESS ON GASTROINTESTINAL CANCER

ESMO 22nd World Congress on Gastrointestinal Cancer

 

1-4 July 2020 Barcelona
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 01/07/2020 TO 01/07/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 29/06/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert